ホーム › 悪性黒色腫 › ノースカロライナ

ノースカロライナにおける悪性黒色腫の臨床試験

ノースカロライナ内の拠点で、悪性黒色腫に関する31件の研究が参加者を募集しています。

ノースカロライナ内の都市

公式研究テキスト（英語）

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Carolina Cancer Research Center, Wilson

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
他6件

被験者募集中観察研究健康なボランティア歓迎

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Lineberger Comprehensive Cancer Center, Chapel Hill

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/30更新 · NCT07740941

DESTINY-PANTUMOUR04

Research Site, Durham
Research Site, Wilson

被験者募集中観察研究

18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
Southeastern Medical Oncology Center-Jacksonville, Jacksonville

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Messino Cancer Center, Asheville
Levine Cancer Institute, Charlotte
Novant Health Cancer Institute, Charlotte
他3件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916

Pan-tumor MRD Study

Carolina Oncology Specialists, Charlotte
Southeastern Medical Oncology Center (SMOC), Goldsboro
Regional Medical Oncology Center, Wilson

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Duke Cancer Center Cary, Cary
Duke University Medical Center, Durham
Duke Cancer Center Raleigh, Raleigh

被験者募集中第3相

75歳以上 · 全性別 · 2026/09/24更新 · NCT07068074

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Carolina Biooncology Institute, Huntersville

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0100, Durham

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Wake Forest University at Clemmons, Clemmons
Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
他4件

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

UNC- Chapel Hill, Chapel Hill

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

University of North Carolina, Chapel Hill

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/09更新 · NCT07288112

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Duke Cancer Institute, Durham

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232

Project: Every Child for Younger Patients With Cancer

Mission Hospital, Asheville
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Carolinas Medical Center/Levine Cancer Institute, Charlotte
他4件

被験者募集中観察研究

25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Lineberger Comprehensive Cancer Center, Chapel Hill

被験者募集中第1相

18歳〜99歳 · 全性別 · 2026/08/19更新 · NCT03454035

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, Huntersville

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/06更新 · NCT07749586

A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

Duke University Medical Center, Durham

被験者募集中第1相

18歳以上 · 全性別 · 2026/07/08更新 · NCT05077137

Integrated Cancer Repository for Cancer Research

Cape Fear Valley Health System, Fayetteville

被験者募集中観察研究健康なボランティア歓迎

19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill

被験者募集中第1/2相

18歳〜70歳 · 全性別 · 2026/06/15更新 · NCT06940739

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Duke University Medical Center, Durham

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/06/08更新 · NCT03947385

IL-17 Blockade to Decrease irAEs (REPLAY)

Duke University Health System, Durham

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/04更新 · NCT07237594

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

University of North Carolina at Chapel Hill, Chapel Hill

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/04/28更新 · NCT06413680

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Duke University Medical Center, Durham

被験者募集中第2/3相

全年齢 · 全性別 · 2026/04/02更新 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Atrium Health Stanly/LCI-Albemarle, Albemarle
Cone Health MedCenter Asheboro, Asheboro
Cone Health Cancer Center at Alamance Regional, Burlington
他21件

被験者募集中観察研究

18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Carolina BioOncology Institute, Huntersville

被験者募集中第1相

18歳以上 · 全性別 · 2026/01/21更新 · NCT07317505

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Duke University Medical Center - Duke Cancer Center, Durham

被験者募集中第3相

18歳以上 · 全性別 · 2025/12/17更新 · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Chapel Hill
Massive Bio SYNERGY-AI site, Winston-Salem

被験者募集中観察研究

全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

Duke University Health System, Durham

被験者募集中

18歳以上 · 全性別 · 2025/09/17更新 · NCT05839912

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
East Carolina University, Greenville
他1件

被験者募集中

18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883

DermaSensor Postmarket Surveillance Study

West Clinical Research, Morehead City

被験者募集中

40歳以上 · 全性別 · 2024/10/31更新 · NCT06666790

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。